Abbott India Q1 results: PAT rises 13% to Rs 328 cr, income at Rs 1,625 cr
Shares of the company on Wednesday ended 1.29 per cent up at Rs 28,159.95 apiece on the BSE. | Representational
Continue readingThe Number One Finance & Business Blog!
Shares of the company on Wednesday ended 1.29 per cent up at Rs 28,159.95 apiece on the BSE. | Representational
Continue readingAbbott Laboratories’ Indian unit has warned of potential supply shortages of two popular laxative syrups after production was prohibited
Continue readingDiagnostics platform Redcliffe Labs is looking to scale up its operations with 250 laboratories and 10,000 collection centres by
Continue reading